Page 87 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

While widespread vaccination is key in our fight against COVID-19, people who are infected still need better treatment to improve their chance of survival and making a full recovery. Early on, the world had high hopes for a range of repurposed medications which had previously been approved to treat other conditions – including hydroxychloroquine, remdesivir and ivermectin – to treat COVID-19. But the results have been disappointing. Diseases caused by viruses are among the most difficult to treat, due to their ability to invade and repurpose infected cells. This limits the ability for drugs to directly act on the virus. Yet researchers around the world are finding ways to overcome these barriers and directly target the coronavirus, including in Australia. So what’s being developed here and how do they work?

United statesNew south walesVasso apostolopoulosVictoria universityElizabeth hall instituteVictor chang cardiac instituteUs national institutes of healthResearchers at queensland menzies health instituteMenzies health instituteQuantum leap healthcare collaborativeNew greekEna respiratoryஒன்றுபட்டது மாநிலங்களில்புதியது தெற்கு வேல்ஸ்விக்டோரியா பல்கலைக்கழகம்எலிசபெத் மண்டபம் நிறுவனம்